Evidence for significant differences in microsomal drug glucuronidation by canine and human liver and kidney.

MLA

Soars, M. G., et al. “Evidence for Significant Differences in Microsomal Drug Glucuronidation by Canine and Human Liver and Kidney.” Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 29, no. 2, Feb. 2001, pp. 121–26. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11159800&authtype=sso&custid=ns315887.

APA

Soars, M. G., Riley, R. J., Findlay, K. A., Coffey, M. J., & Burchell, B. (2001). Evidence for significant differences in microsomal drug glucuronidation by canine and human liver and kidney. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 29(2), 121–126.

Chicago

Soars, M G, R J Riley, K A Findlay, M J Coffey, and B Burchell. 2001. “Evidence for Significant Differences in Microsomal Drug Glucuronidation by Canine and Human Liver and Kidney.” Drug Metabolism and Disposition: The Biological Fate of Chemicals 29 (2): 121–26. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11159800&authtype=sso&custid=ns315887.